Press Release

Cardiac Biomarkers Market Size Overview by Industry Trends, Share, Growth Factor and Analysis to 2026

Cardiac Biomarkers Market Global Industry Analysis, Potential Growth, Key Players, Latest Trends

The acute coronary syndrome sub-segment under application segment is projected to dominate the global cardiac biomarkers market during the forecast period. It is likely to occur due to a rise in the investment by various health institutes in biomarker testing for early detection of the disease. This information is given in an upcoming report by Fortune Business Insights, titled, “Cardiac Biomarkers Market Size, Share and Global Trend By Type (Troponin, Creatine kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), and N-terminal pro b-type natriuretic peptide (NT-proBNP), Myoglobin), By Application (Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure), By End User (Hospitals, Diagnostic Centers, Homecare Settings) and Geography Forecast till 2026.”

For more information in the analysis of this report, visit:

Roche, a multinational healthcare company, headquartered in Switzerland, announced that FDA approved it’s Elecsys Troponin T Gen 5 STAT (TnT Gen 5 STAT) blood test in January 2017. The test would support in promptly identifying patients who are suspected of myocardial infarction. The test is currently available across the globe for the last seven years. During its presence in the global market, extensive research and studies about it were conducted in almost 600 publications. Emergency clinicians and doctors nowadays look for safety and accuracy in detecting chances of heart attacks. It is often fueled by troponin assay. But FDA’s approval of Elecsys would boost the emergency medication sector.

Fortune Business Insights has further profiled some of the prominent market players operating in the global cardiac biomarkers market. They are as follows:

  • Thermo Fisher Scientific
  • Abbott
  • Becton
  • Bio-Rad Laboratories, Inc.
  • Hoffmann-La Roche Ltd.
  • Randox Laboratories Ltd.
  • Beckman Coulter, Inc.
  • Dickinson and Company
  • Dickinson and Company
  • bioMérieux SA
  • Other key market players

Request a Sample Copy of the Global Cardiac Biomarkers Market Research Report:

Global Cardiac Biomarkers Market Segmentation

By Type

  • Troponin
  • Creatine kinase-MB (CK-MB)
  • B-type Natriuretic Peptide (BNP), and N-terminal pro b-type natriuretic peptide (NT-proBNP)
  • Myoglobin
  • Others

By Application

  • Acute Coronary Syndrome
  • Myocardial Infarction
  • Congestive Heart Failure
  • Others

By End User

  • Hospitals
  • Diagnostic Centers
  • Homecare Settings
  • Others

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

More Trending Topics From Fortune Business [email protected]

Ophthalmic Disease Therapeutics Market Global Industry Size, Growth, Segments, Revenue, Manufacturers and 2026 Forecast Research Report

Lung Cancer Therapeutics Market a US$ 48,725.9 Million Industry..! What is Driving the market?

Global Sterilization Wraps Market 2026 | Revenue & Growth Forecast by Product, Material & Industry Players

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *